Growth Metrics

Tandem Diabetes Care (TNDM) EBT Growth (1y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -18.50%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 11.26%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -8.83%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 44.35%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 5.78%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 103.34%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 74.66%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -27.02%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 54.33%
10 Tandem Diabetes Care 1.31 Bn 739.55 Mn 136.79 Mn 83.72%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 83.72%
Dec 31, 2025 15,660.00%
Sep 30, 2025 -11.18%
Jun 30, 2025 -94.07%
Mar 31, 2025 -208.86%
Dec 31, 2024 100.10%
Sep 30, 2024 26.34%
Jun 30, 2024 14.04%
Mar 31, 2024 68.01%
Dec 31, 2023 -94.58%
Sep 30, 2023 35.16%
Jun 30, 2023 -167.18%
Mar 31, 2023 -653.57%
Dec 31, 2022 -245.16%
Sep 30, 2022 -909.66%
Jun 30, 2022 -418.26%
Mar 31, 2022 -217.77%
Dec 31, 2021 -34.85%
Sep 30, 2021 162.42%
Jun 30, 2021 113.94%
Mar 31, 2021 65.06%
Dec 31, 2020 524.33%
Sep 30, 2020 -231.18%
Jun 30, 2020 -1,830.03%
Mar 31, 2020 35.76%
Dec 31, 2019 -27.01%
Sep 30, 2019 91.74%
Jun 30, 2019 88.96%
Mar 31, 2019 -49.36%
Dec 31, 2018 139.26%
Sep 30, 2018 -161.29%
Jun 30, 2018 27.56%
Mar 31, 2018 27.27%
Dec 31, 2017 28.44%
Sep 30, 2017 53.82%
Jun 30, 2017 -11.58%
Mar 31, 2017 -10.70%
Dec 31, 2016 -19.56%
Sep 30, 2016 -52.45%
Jun 30, 2016 8.94%
Mar 31, 2016 5.86%
Dec 31, 2015 36.28%
Sep 30, 2015 1.90%
Jun 30, 2015 -1.77%
Mar 31, 2015 2.44%
Dec 31, 2014 -6.15%
Sep 30, 2014 -56.49%
Jun 30, 2014 -33.71%
Mar 31, 2014 -190.49%